Resveratrol supplements lower blood glucose in Type 2 Diabetes patients

A recent study of resveratrol supplementation for people with Type 2 diabetes confirms the benefit of the supplement. The diabetes patients were under treatment at the time of the study. After 45 days, the study group taking the resveratrol instead of the placebo showed significantly decreased systolic blood pressure, fasting blood glucose, hemoglobin A1c, insulin, and insulin resistance, while their HDL (the so-called “good cholesterol”) was significantly increased, when compared to their baseline levels. The authors of the research conclude that resveratrol exerts “strong antidiabetic effects in patients with type 2 diabetes.”

While this study reinforces findings about the benefits of supplementing with resveratrol for people with Type 2 diabetes, we at NYBC would like to repeat our recommendation to discuss with your healthcare provider any use of the supplement as part of your ongoing treatment for diabetes.

See the NYBC catalog for further information:



Movahed, A et al. Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients. Evidence Based Complementary Alternative Medicine. 2013;2013:851267. doi: 10.1155/2013/851267. Epub 2013 Sep 1.

CATIE booklet on side effects

CATIE, the venerable and sharp Canadian AIDS Treatment Information Exchange, has once again provided a terrific manual entitled A Practical Guide to HIV Drug Side Effects (link – ).

The booklet, available as a pdf by clicking the link above, covers a wide array of topics. The language is clear and the layout is easy to follow. They provide information on mainstream medical and “alternative” or natural remedies to manage what can be debilitating side effects of HIV therapy.

Topics covered include the range found in the table of contents:

This Guide Is One Tool to Healthy Living
4 Dealing with Side Effects
8 My Health Map
10 Body Weight and Body Shape Changes
14 Diarrhea, Gas and bloating
17 Emotional wellness
21 Fatigue
24 Headaches
27 Menstrual changes
31 Mouth and throat problems
35 Muscle aches and pains
38 Nausea, vomiting and appetite loss
42 Nerve pain and numbness
44 Rash and other problems of the skin,
hair and nails
47 Sexual difficulties
49 Sleep problems
53 Less common side effects: lactic acidosis,
pancreatitis and abacavir hypersensitivity
55 Appendix: Vitamin B12 and Vitamin D
57 More Resources

Resveratrol: more evidence of its potential benefits

Resveratrol, found in red wine and now widely used as a supplement, is back in the news this month. A research report in the highly respected journal Science identifies the precise mechanism by which resveratrol regulates sirtuins, proteins in the body which have been linked to the prevention of many age-related diseases such as cancer, Alzheimer’s, and Type-2 diabetes.

This finding adds further support to the idea that resveratrol or a derivative of resveratrol might represent a breakthrough treatment for some of the major disease threats faced by humans as they age.

We first read about the new research in our hometown paper, The New York Times, but the story has been widely reported. (See reference to the article in Science below.)

NYBC stocks Resveratrol and Resveratrol Synergy from Jarrow. Of course we’d welcome any reports from our members about their use of these products.

Reference: Hubbard, et al. Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science, March 8, 2013.

Alpha lipoic acid for diabetic sensory neuropathy

A recent review article suggested that a dose of 600 mg alpha lipoic acid (ALA) daily administered for up to 5 weeks could offer benefits in symptoms of diabetic sensory neuropathy without significant side effects. This review also notes that ALA is already approved for treatment of neuropathy in Germany. Furthermore, it seems obviously a better choice than the opioids often prescribed for diabetic neuropathy pain, as these induce addiction.

For more on alpha lipoic acid, see the NYBC entries:
Jarrow ALA sustained and Montiff ALA. NYBC also stocks Jarrow ALA plus Biotin; biotin is a B vitamin that has also been recommended for diabetes.


McIlduff CE, Rutkove SB, Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy. Therapeutics and Clinical Risk Management. Sept. 2011 Volume 2011:7 Pages 377 – 385

National Institutes of Health: How Resveratrol Works

Resveratrol, a compound found most famously in red wine, is the subject of a Feb. 13, 2012 news release by the National Institutes of Health. The NIH reports on a new study that identified the precise biochemical mechanism in the body that seems to be responsible for resveratrol’s ability to mitigate the harmful health effects of a high-fat diet.

One of the earliest reasons for scientific interest in resveratrol was the perception that people who drank a lot of red wine could also eat a relatively high fat diet, yet still have a rather low risk of cardiovascular disease. (This was the so-called “French paradox,” much discussed in the US media in the early 1990s.) The current NIH-supported study found evidence that resveratrol affects specific biochemical pathways that block the ill effects of a high-fat diet, such as obesity, glucose intolerance, and, potentially, the development of Type 2 diabetes. (Type 2 diabetes, in turn, is a risk factor for coronary heart disease.)

This NIH-supported study follows a pattern we’ve often seen before: the health benefits of a natural product are noted in general population studies, and eventually laboratory science allows us to home in on the exact mechanisms by which the natural substance works. Needless to say, we’re all for this kind of research to confirm and refine our knowledge of supplements!

Read more about the resveratrol study at:

You can find resveratrol in two forms at the NYBC. (Resveratrol Synergy adds some of the additional parts of the grape that are thought to have health benefits, and combines those with green tea extract, another food extract that researchers believe may have health benefits.)

Resveratrol Synergy

Alpha Lipoic Acid and Type 2 Diabetes

There is growing evidence that Alpha Lipoic Acid (ALA) has beneficial effects on the treatment of Type 2 Diabetes and some of its complications. Its wide-ranging benefits for diabetes include improved glycemic control, improved insulin sensitivity, reduction of oxidative stress, and reduction of neuropathy.

A recent review of ALA for diabetes concluded that the supplement’s side effects were generally limited, and found that it was generally safe for use even by those with impaired kidney or liver function. (NYBC adds only a caution about a potential thyroid issue, especially for those taking higher doses of ALA.)

See the NYBC entry

Alpha Lipoic with Biotin


Poh Z, Goh KP. A current update on the use of alpha lipoic Acid in the management of type 2 diabetes mellitus. Endocr Metab Immune Disord Drug Targets. 2009 Dec;9(4):392-398.

Resveratrol and Resveratrol Synergy supplements

We were interested to see in today’s online edition of our hometown newspaper, The New York Times, a news report on the latest research about resveratrol and related compounds:

“Drug Is Found to Extend the Lives of Obese Mice”

The article points to the promise of continuing research on resveratrol derivatives, while also reviewing some of the questions that remain before large-scale human trials of the sort that can lead the breakthroughs in drug development. One of NYBC’s concerns, as always, has been that the real benefits of the non-prescription supplement itself could be ignored in the quest for some patentable super-drug (which would undoubtedly make the pharmaceutical company rich, no doubt!)

So, to review, there have been a number of research developments in just the past couple of years about the basic resveratrol molecule itself–the very same one that you can find in supplements now stocked by NYBC. Here’s an excerpt from our post earlier this year:

For a while it seemed like the excitement about resveratrol–the molecule famously found in red wine–had died down.

A few years ago widely publicized studies showed that resveratrol had potential as a life-extending supplement (it showed that capacity in lab animals). And there was buzz when companies raised hundreds of millions in venture capital to explore the possibilities further. One catch with that high-profile research was that it involved very high doses of resveratrol. (The equivalent of drinking hundreds of bottles of red wine a day!)

However, in just the past couple of years, scientific interest has come back to resveratrol, and this time it is pointing to substantial health benefits without those massive doses.

First, cardiovascular health. In 2009, a Univ. of Wisconsin research team reported that low doses of resveratrol in the diet of middle-aged mice could have many of the same effects as the high dose reseveratrol, especially in terms of protecting heart health. Second, in 2010, Johns Hopkins researchers reported on a mechanism by which resveratrol shielded mice from stroke damage to the brain. A single small dose of the compound increased levels of an enzyme that protects nerve cells in the brain from damage when blood flow is disrupted by stroke.

It’s also just been announced that the scientific research organization of Denmark will run a multi-year study of resveratrol for diabetes. This announcement follows the news from December 2010 that our hometown Albert Einstein Medical Center has been awarded an NIH grant, also for a study of resveratrol and diabetes.

All in all, resveratrol seems to remain a very promising research topic!

You can find resveratrol in two forms at the NYBC. (Resveratrol Synergy adds some of the additional parts of the grape that are thought to have health benefits, and combines those with green tea extract, another food extract that researchers believe may have health benefits.)


Resveratrol Synergy